Search by property
Appearance
This page provides a simple browsing interface for finding entities described by a property and a named value. Other available search interfaces include the page property search, and the ask query builder.
List of results
- Sharp et al. (2010): A randomised, controlled trial of the psychological effects of reflexology in early breast cancer + (NI)
- Wyatt et al. (2012): Health-Related Quality-of-Life Outcomes: A Reflexology Trial With Patients With Advanced-Stage Breast Cancer + (NI)
- Mansouri et al. (2016): The Effect of Aloe Vera Solution on Chemotherapy-Induced Stomatitis in Clients with Lymphoma and Leukemia: A Randomized Controlled Clinical Trial + (NI)
- Ryan et al. (2011): Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: a URCC CCOP study of 576 patients + (NI)
- Lin et al. (2010): Discrepancy of the effects of zinc supplementation on the prevention of radiotherapy-induced mucositis between patients with nasopharyngeal carcinoma and those with oral cancers: subgroup analysis of a double-blind, randomized study + (Nasopharyngeal Cancer: daily fractionation … Nasopharyngeal Cancer: daily fractionations of 180 cGy to 200 cGy in 5 weekly fractions; total dose: 7000 cGy</br></br>Oral Cancer: 7000 cGy was given to patients without surgery and 6000 cGy was prescribed as adjuvant treatment if they received an operation,</br>unilateral irradiation was performed for cancers arising from retromolar, unilateral gum, lip, or single focus of buccal mucosa; whereas bilateral irradiation was done for tumors arising from mouth floor or multiple foci of buccal mucosath floor or multiple foci of buccal mucosa)
- Mazdak et al. (2012): Vitamin E reduces superficial bladder cancer recurrence: A randomized controlled Trial + (No intravesical chemotherapy)
- Johnson et al. (2010): Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain + (No therapy in the last 2 weeks)
- Su et al. (2004): Phase II double-blind randomized study comparing oral aloe vera versus placebo to prevent radiation-related mucositis in patients with head-and-neck neoplasms + (Of the 58 patients, 41% underwent primary surgical resection with adjuvant radiotherapy, and 59% received definitive radiotherapy; 41% of patients also received concurrent chemotherapy. Chemotherapy per arm: Aloe arm: 36% Placebo arm: 47%)
- Rao et al. (2014): The Indian Spice Turmeric Delays and Mitigates Radiation-Induced Oral Mucositis in Patients Undergoing Treatment for Head and Neck Cancer: An Investigational Study + (Only radiation therapy, radiation therapy + chemotherapy or radiation therapy + chemotherapy + surgery)
- Koyama et al. (2017): Intravenous Carnitine Administration in Addition to Parenteral Nutrition With Lipid Emulsion May Decrease the Inflammatory Reaction in Postoperative Surgical Patients + (Open or Laparoscopic surgery for gastric or colorectal cancer + Peripheral postoperative parenteral nutrition (PPN): glucose, amino acid, lipid emulsion)
- Akiba et al. (2018): Vitamin D Supplementation and Survival of Patients with Non–small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial + (Oral or injection chemotherapy was administered to the patients according to the stage, except in stage IA and tumor size less than 2 cm)
- Vitale et al. (2020): ZeOxaNMulti Trial: A Randomized, Double-Blinded, Placebo-Controlled Trial of Oral PMA-Zeolite to Prevent Chemotherapy-Induced Side Effects, in Particular, Peripheral Neuropathy + (Oxaliplatin, 1. or 2. line)
- Afonseca et al. (2013): Vitamin E for prevention of oxaliplatin-induced peripheral neuropathy: A pilot randomized clinical trial + (Oxaliplatin-based chemotherapy + calcium and magnesium supplements before and after oxaliplatin infusions)
- Salehi et al. (2015): Effect of Vitamin E on Oxaliplatin-induced Peripheral neuropathy Prevention: A Randomized Controlled Trial + (Oxiplatin-based chemotherapy (oxaliplatin … Oxiplatin-based chemotherapy (oxaliplatin + 5‑fluorouracil + leucovorin (FOLFOX4); oxaliplatin: 85 mg/m 2 intravenous (IV) on day 1, 5‑fluorouracil: 400 mg/m 2 IV bolus, followed by 600 mg/m 2 IV continuous infusion for 22 h on days 1 and 2, leucovorin: 200 mg/m 2 IV on days 1 and 2 as a 2‑h infusion before 5‑fluorouracil)2 as a 2‑h infusion before 5‑fluorouracil))
- Argyriou et al. (2006): Preventing Paclitaxel-Induced Peripheral neuropathy: A Phase 2 Trial of Vitamin E Supplementation + (Paclitaxel-based chemotherapy)
- Panahi et al. (2012): Effect of Ginger on Acute and Delayed Chemotherapy-Induced Nausea and Vomiting: A Pilot, Randomized, Open-Label Clinical Trial + (Patients experiencing their first trial of chemotherapy (Docetaxel, Epirubicin, Cyclophosphamid))
- Zick et al. (2008): Phase II trial of encapsulated ginger as a treatment for chemotherapy-induced nausea and vomiting + (Patients must have had at least one previous round of chemotherapy.)
- Nguyen et al. (2012): Randomized, Double-Blind, Placebo-Controlled Trial of Polyphenon E in Prostate Cancer Patients before Prostatectomy: Evaluation of Potential Chemopreventive Activities + (Patients received no other therapy for their prostate cancer; no history of chemotherapy and/or radiation for any malignancy in the previous 5 years)
- Emami et al. (2014): Double-blinded, randomized, placebo-controlled study to evaluate the effectiveness of green tea in preventing acute gastrointestinal complications due to radiotherapy + (Patients receiving standardized abdomen an … Patients receiving standardized abdomen and pelvic irradiation 5000 cGy (1000 cGy weekly)</br></br>Cancer treatments: per arm n(%)</br>Radiotherapy + chemotherapy: green tea arm 8(38.1); Placebo arm 7(33.3)</br>Radiotherapy + surgery: green tea arm 16(76.2); Placebo arm 16(76.2)een tea arm 16(76.2); Placebo arm 16(76.2))
- Vinzenz et al. (1992): Die Therapie der radiogenen Mukositis mit Enzymen + (Patients underwent preoperative radiotherapy)
- Shokri et al. (2017): Comparison of the Complications of Platinum-Based Adjuvant Chemotherapy With and Without Ginger in a Pilot Study on Ovarian Cancer Patients + (Patients who underwent cytoreductive surgery followed by platinum-based adjuvant chemotherapy)
- Wrbka et al. (1987): Unterstützung der Chemotherapie inoperabler Karzinome durch proteolytische Fermente + (Patients with untreated inoperable bronchopulmonary carcinomas of various entities; 4 out of 51 patients had previously undergone surgery or radiotherapy for carcinoma in another organ)
- Lissoni et al. (1998): Biotherapy with the Pineal Immunomodulating Hormone Melatonin versus Melatonin plus Aloe vera in Untreatable Advanced Solid Neoplasms + (Patients, for whom no other effective stan … Patients, for whom no other effective standard therapy was available, because of lack of response to previous chemotherapies or a poor clinical status precluding chemotherapy.</br></br></br>Previous chemotherapy </br></br>(patients were eligible after at least 1 month from the last chemotherapy course):</br></br>Aloe arm: 20/24</br></br>Control arm: 21/26rse): Aloe arm: 20/24 Control arm: 21/26)
- Jatoi et al. (2002): Dronabinol Versus Megestrol Acetate Versus Combination Therapy for Cancer-Associated Anorexia: A North Central Cancer Treatment Group Study + (Planned concurrent chemotherapy, %, per ar … Planned concurrent chemotherapy, %, per arm</br>* None: Megestrol Acetate = 30; Dronabinol = 30; Megestrol Acetate + Dronabinol= 30</br></br>* With cisplatinum: Megestrol Acetate = 15; Dronabinol = 14; Megestrol Acetate + Dronabinol = 14</br></br>* Without cisplatinum: Megestrol Acetate= 55; Dronabinol = 56; Megestrol Acetate + Dronabinol = 56</br></br></br>Planned concurrent radiation, %</br></br>* Yes: Megestrol Acetate = 21; Dronabinol = 20; Megestrol Acetate + Dronabinol = 20</br></br>* No: Megestrol Acetate = 79; Dronabinol = 80; Megestrol Acetate + Dronabinol = 80 = 80; Megestrol Acetate + Dronabinol = 80)
- Halyard et al. (2007): Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4) + (Planned radiation dose ≥6,000 vs. ≤6,000 cGy; n=71 with concomitant chemotherapy anticipated)
- Cavallini et al. (2005): Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomy + (Post-Surgery: bilateral nerve-sparing radical retropubic prostatectomy)
- Fallahi et al. (2013): Does vitamin E protect salivary glands from I-131 radiation damage in patients with thyroid cancer? + (Postsurgical ablation therapy with 3700–5550MBq <sup>131</sup>I)
- Urashima et al. (2019): Effect of Vitamin D Supplementation on Relapse-Free Survival Among Patients With Digestive Tract Cancers The AMATERASU Randomized Clinical Trial + (Preoperative and postoperative chemotherap … Preoperative and postoperative chemotherapy was administered to patients with stage II and III esophageal cancer; postoperative chemotherapy was administered to patients with stage II and III gastric cancer and all patients with stage III colorectal cancer;</br>Local radiation or molecular-targeting therapy was combined with chemotherapy for selected patients with relapsetherapy for selected patients with relapse)
- Sun et al. (2016): A prospective study to evaluate the efficacy and safety of oral acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy + (Previous Satraplatin or Vincristine chemotherapy, but not recently or at the time of the study)
- Puataweepong et. al (2009): The efficacy of oral Aloe vera juice for radiation induced mucositis in head and neck cancer patients: a double-blind placebo-controlled study + (Previous surgery Aloe arm: 4 (13%) Placebo arm: 12 (38%) Chemotherapy Aloe arm: yes = 17 (57%); no = 13 (43%) Placebo arm: yes = 18 (58%); no = 13 (42%))
- Jyothirmayi et al. (1996): Efficacy of Vitamin A in the Prevention of Locoregional Recurrence and Second Primaries in Head and Neck Cancer + (Previous treatment per group: - intervention: 44x radiotherapy, 3x surgery, 3x radiotherapy + surgery - placebo: 47x radiotherapy, 5x surgery, 4x radiotherapy + surgery)
- Sangthawan et al. (2013): A randomized double-blind, placebo-controlled trial of zinc sulfate supplementation for alleviation of radiation-induced oral mucositis and pharyngitis in head and neck cancer patients + (Radiation therapy alone or as postoperative radiation therapy, all patients were treated with Cobalt-60 or 6 MV photon machine, daily fractionation was 1.8 to 2 Gy, a total dose of 50 to 70 Gy over 5 to 7 weeks was administered)
- Nasser et al. (2017): Vitamin D ointment for prevention of radiation dermatitis in breast cancer patients + (Radiation therapy to the involved breast w … Radiation therapy to the involved breast was delivered by two tangential fields, delivered as a single fraction per day, 5 days a week;</br>radiation dose was either 42.72 Gy in 16 fractions or 50 Gy in 25 fractions, when indicated, a boost was provided to the tumor bed, to a total dose of 10 Gy administered in 5 fractions of 2 Gy eachy administered in 5 fractions of 2 Gy each)
- Togni et al. (2015): Clinical evaluation of safety and efficacy of Boswellia-based cream for prevention of adjuvant radiotherapy skin damage in mammary carcinoma: a randomized placebo controlled trial + (Radiation therapy with 2 tangential fields with a photonbeam energy of 6 Mv 50 Gy, 5 doses weekly about 5 weeks)
- Stauder et al. (1991): Strahlentherapeutische Nebenwirkungen bei Abdominalkrebspatienten und deren Reduktion durch hydrolytische Enzyme + (Radiation treatment of patients with inoperable abdominal cancer or postoperative radiotherapy of abdominal cancer due to lymph node involvement.)
- Margalit et al. (2012): Beta-carotene Antioxidant Use During Radiation Therapy and Prostate Cancer Outcome in the Physicians’ Health Study + (Radiation type per group: - intervention: 129x external beam radiation, 39x brachytherapy, 21x both, 2x unknown or missing - placebo: 133x external beam radiation, 40x brachytherapy, 16x both, 3x unknown or missing)
- Liu et al. (2010): Influence of vitamin C on salivary absorbed dose of 131I in thyroid cancer patients: a prospective, randomized, single-blind, controlled trial + (Radioiodine therapy (131I))
- Dos Santos Martins (2016): Placebo-Controlled, Double-Blind, Randomized Study of a Dry Guarana Extract in Patients with Head and Neck Tumors Undergoing Chemoradiotherapy: Effects on Fatigue and Quality of Life + (Radiotherapy consisted of 30 daily session … Radiotherapy consisted of 30 daily sessions lasting six weeks (total dose = 5,040 cGys in the supraclavicular fossa and lymphatic drainages and reaching 7,040 cGys in the tumor).</br>Platinum-based chemotherapy consisted of three cycles of cisplatin (100 mg/m2) every 21 days during the chemoradiotherapy.very 21 days during the chemoradiotherapy.)
- Moslemi et al. (2014): Oral zinc sulphate and prevention of radiation-induced oropharyngealmucositis in patients with head and neck cancers: A double blind, randomized controlled clinical trial + (Radiotherapy doses (cGy) Range: 4000-7000; concurrent chemoradiotherapy: n=32)
- Côté et al. (2016): Improving Quality of Life With Nabilone During Radiotherapy Treatments for Head and Neck Cancers: A Randomized Double-Blind Placebo-Controlled Trial + (Radiotherapy only: intervention arm = 13 … Radiotherapy only: </br></br>intervention arm = 13; placebo arm = 10</br></br>Radiotherapy postoperative: </br></br>intervention arm = 7; placebo arm = 2</br></br>Radiochemotherapy: </br></br>intervention arm = 7; placebo arm = 15</br></br>Radiochemotherapy postoperative: </br></br>intervention arm = 1, placebo arm = 1e: intervention arm = 1, placebo arm = 1)
- Mix et al. (2015): Randomized phase II trial of selenomethionine as a modulator of efficacy and toxicity of chemoradiation in squamous cell carcinoma of the head and neck + (Radiotherapy: 70 Gy at 2 Gy per fraction in 35 daily treatments, 5 days a week for 7 weeks, chemotherapy: Cisplatin dosed at 100 mg/m² intravenously over 3h in 1000mL saline on days 1, 22, and 43 of radiotherapy)
- Watanabe et al. (2010): Polaprezinc prevents oral mucositis associated with radiochemotherapy in patients with head and neck cancer + (Radiotherapy: n=10, Radiochemotherapy: n=21)
- Toma et al. (2003): β-carotene supplementation in patients radically treated for stage I-II head and neck cancer: Results of a randomized trial + (Randomization within 1 month after assessment of complete response to treatment)
- Uysal et al. (2016): Effects of foot massage applied in two different methods on symptom control in colorectal cancer patients: Randomised control trial + (Receiving chemoradiationtherapy during postoperative and preoperative periods)
- Antunac et al. (2018): Vitamin D Supplementation and Survival in Metastatic Colorectal Cancer + (Regimen: FOLFIRI, Oxaliplatinum based or 5 FU-based)
- Howells et al. (2011): Phase I randomised double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases - safety, pharmacokinetics and pharmacodynamics + (Resection of liver metastases)
- Yap et al. (2017): Predictors of hand-foot syndrome and pyridoxine for prevention of capecitabine-induced hand-foot syndrome: a randomized clinical trial + (Single-agent capecitabine chemotherapy)
- Özdelikara et al. (2017): The effect of reflexology on the quality of life with breast cancer patients + (Standard antiemetic doses)
- Ryan et al. (2013): Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients + (Standard fractionated RT (~1.8–2.4 Gy per session) for four to seven weeks with or without boost for a total radiation dose of ≥ 42 Gy Prior (n(%)): * Lumpectomy 27 (90%) * Mastectomy 3 (10%) * Chemotherapy before radiation 13 (43.3%))
- Henning et al. (2015): Randomized Clinical Trial of Brewed Green and Black Tea in Men With Prostate Cancer Prior to Prostatectomy + (Study setting is prior to surgery.)
- Kessels et al. (2017): Topical Sinecatechins, 10%, Ointment for Superficial Basal Cell Carcinoma A Randomized Clinical Trial + (Study setting is prior to surgery.)